Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00248716
Status:
UNKNOWN
Last Update Posted:
2008-05-06
First Post:
2005-11-03
Brief Title:
Treatment of Anemia in the 2nd Year of Life Comparison of the Efficacy of Two Different Iron Preparations
Sponsor:
Soroka University Medical Center
Organization:
Soroka University Medical Center
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2008-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Healthy toddlers age 9-18 month following a routine blood count will be placed in three groups
1 Iron deficiency with no anemia
2 anemia
3 no anemia and no iron deficiency Following a nutritional questionnaire parents of all toddlers will receive instruction regarding appropriate nutrition in the 2nd year of life Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron polysaccharide complex Followup blood count will be taken 3 month after recruitment The study aims to compare the effectiveness of the Iron preparations regarding compliance and efficacy
The hypothesis is that a significant difference will be detected between the two preparations
1 Iron deficiency with no anemia
2 anemia
3 no anemia and no iron deficiency Following a nutritional questionnaire parents of all toddlers will receive instruction regarding appropriate nutrition in the 2nd year of life Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron polysaccharide complex Followup blood count will be taken 3 month after recruitment The study aims to compare the effectiveness of the Iron preparations regarding compliance and efficacy
The hypothesis is that a significant difference will be detected between the two preparations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None